1. Home
  2. BRNS vs CMBM Comparison

BRNS vs CMBM Comparison

Compare BRNS & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRNS
  • CMBM
  • Stock Information
  • Founded
  • BRNS 2016
  • CMBM 2011
  • Country
  • BRNS United Kingdom
  • CMBM United States
  • Employees
  • BRNS N/A
  • CMBM N/A
  • Industry
  • BRNS Biotechnology: Pharmaceutical Preparations
  • CMBM Radio And Television Broadcasting And Communications Equipment
  • Sector
  • BRNS Health Care
  • CMBM Technology
  • Exchange
  • BRNS Nasdaq
  • CMBM Nasdaq
  • Market Cap
  • BRNS 36.0M
  • CMBM 9.6M
  • IPO Year
  • BRNS 2021
  • CMBM 2019
  • Fundamental
  • Price
  • BRNS $1.00
  • CMBM $0.40
  • Analyst Decision
  • BRNS Strong Buy
  • CMBM Strong Buy
  • Analyst Count
  • BRNS 1
  • CMBM 2
  • Target Price
  • BRNS $3.00
  • CMBM $5.50
  • AVG Volume (30 Days)
  • BRNS 11.6K
  • CMBM 997.1K
  • Earning Date
  • BRNS 08-07-2025
  • CMBM 08-07-2025
  • Dividend Yield
  • BRNS N/A
  • CMBM N/A
  • EPS Growth
  • BRNS N/A
  • CMBM N/A
  • EPS
  • BRNS N/A
  • CMBM N/A
  • Revenue
  • BRNS $14,969,000.00
  • CMBM $172,215,000.00
  • Revenue This Year
  • BRNS N/A
  • CMBM N/A
  • Revenue Next Year
  • BRNS N/A
  • CMBM $17.87
  • P/E Ratio
  • BRNS N/A
  • CMBM N/A
  • Revenue Growth
  • BRNS 4381.74
  • CMBM N/A
  • 52 Week Low
  • BRNS $0.64
  • CMBM $0.23
  • 52 Week High
  • BRNS $1.58
  • CMBM $2.50
  • Technical
  • Relative Strength Index (RSI)
  • BRNS 53.30
  • CMBM 52.56
  • Support Level
  • BRNS $0.90
  • CMBM $0.38
  • Resistance Level
  • BRNS $0.94
  • CMBM $0.43
  • Average True Range (ATR)
  • BRNS 0.05
  • CMBM 0.04
  • MACD
  • BRNS 0.00
  • CMBM 0.01
  • Stochastic Oscillator
  • BRNS 96.80
  • CMBM 54.61

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

About CMBM Cambium Networks Corporation

Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.

Share on Social Networks: